Prognosis in patients with hepatocellular carcinoma correlates to mutations of p53 and/or hMSH2 genes
スポンサーリンク
概要
- 論文の詳細を見る
Association of gene alterations and prognosis has not fully been elucidated in hepatocellular carcinoma (HCC). To clarify the relationship between p53 and hMSH2 mutations and prognosis, we analysed these mutations in 83 HCC cases and assessed their association with various clinicopathological factors. The 3-year disease-free survival (DFS) or overall survival (OS) rates in HCC patients with p53 mutation and p53 wild/hMSH2 mutation significantly decreased compared with those without these mutations (14.3-0x1.f824p+0nd 37.5% versus 67.5-0.000000or DFS; 35.7-0x1.f5cf80852f11p+0nd 50.0% versus 96.4-0.000000or OS, respectively). In the multivariate analysis, categories by p53 and hMSH2 mutation status, and liver cirrhosis demonstrated statistical significances for DFS and OS. Moreover, the frequency of patients with p53 and/or hMSH2 mutations in intrahepatic metastasis (75.0%) was significantly higher than that in multicentric occurrence (14.3%). Thus, p53 and hMSH2 mutations will be useful for identifying subsets of HCC patients with poor prognosis.
論文 | ランダム
- この国は大丈夫か--民主党政権の幼稚さとしたたかな中国 (ぶち抜き大特集 ニッポンよ、どこへ行く)
- 世界の構造転換と日本、そして港湾
- 講演要旨 最近の日米関係[含 質疑応答]
- 特別講演 アジア太平洋への視界 (特集 新たな潮流を切り拓く挑戦的なロジスティクス戦略の創造--ロジスティクス関西大会2010)
- この戦略3分野で日本再生を狙う。「プロジェクト・マネジメント・スペシャリスト」育成が急務だ (SIMULATION REPORT 日本憂国論をぶっとばせ! 「勝てる日本の作り方」を考える)